Skip to Main Content

Paper Details

CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer.
Cancer Res
11
2023
Adenosine, Adora2b, CD73, CD8, CD8+, CD8+ T cells, CD8+ T-cell, CD8+GZM+ T-cell, Ductal Pancreatic Cancer, Ductal-derived pancreatic tumors, GZM+, NT5E, Nt5e, PDAC, PDAC tumor, acinar cells, adenosine, adenosine receptor Adora2b, cell-, cell-of, ductal cell, ductal cell of origin, genes, human, immunosuppression, mouse, murine, pancreatic ductal adenocarcinoma, tumor, tumors
Author NameAffiliation
Yulin DaiCenter for Precision Health, The University of Texas Health Science Center at Houston
Nirav ThosaniMcGovern Medical School, The University of Texas Health Science Center at Houston
Nirav ThosaniCenter for Interventional Gastroenterology at UTHealth (iGUT), McGovern Medical School, The University of Texas Health Science Center at Houston
Zhongming ZhaoCenter for Precision Health, The University of Texas Health Science Center at Houston
Powel H BrownThe University of Texas MD Anderson Cancer Center
Florencia McAllisterThe University of Texas MD Anderson Cancer Center
Florencia McAllisterThe University of Texas MD Anderson Cancer Center, and The University of Texas Health Science Center at Houston
Florencia McAllisterThe University of Texas MD Anderson Cancer Center
Florencia McAllisterThe University of Texas MD Anderson Cancer Center
  • 1 - 9

Datasets

Release 1.2